389 related articles for article (PubMed ID: 27072494)
1. Exenatide exerts direct protective effects on endothelial cells through the AMPK/Akt/eNOS pathway in a GLP-1 receptor-dependent manner.
Wei R; Ma S; Wang C; Ke J; Yang J; Li W; Liu Y; Hou W; Feng X; Wang G; Hong T
Am J Physiol Endocrinol Metab; 2016 Jun; 310(11):E947-57. PubMed ID: 27072494
[TBL] [Abstract][Full Text] [Related]
2. Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans.
Koska J; Sands M; Burciu C; D'Souza KM; Raravikar K; Liu J; Truran S; Franco DA; Schwartz EA; Schwenke DC; D'Alessio D; Migrino RQ; Reaven PD
Diabetes; 2015 Jul; 64(7):2624-35. PubMed ID: 25720388
[TBL] [Abstract][Full Text] [Related]
3. Liraglutide ameliorates palmitate-induced oxidative injury in islet microvascular endothelial cells through GLP-1 receptor/PKA and GTPCH1/eNOS signaling pathways.
Le Y; Wei R; Yang K; Lang S; Gu L; Liu J; Hong T; Yang J
Peptides; 2020 Feb; 124():170212. PubMed ID: 31770577
[TBL] [Abstract][Full Text] [Related]
4. A GLP-1 analog lowers ER stress and enhances protein folding to ameliorate homocysteine-induced endothelial dysfunction.
Cheng CK; Luo JY; Lau CW; Cho WC; Ng CF; Ma RCW; Tian XY; Huang Y
Acta Pharmacol Sin; 2021 Oct; 42(10):1598-1609. PubMed ID: 33495519
[TBL] [Abstract][Full Text] [Related]
5. GLP-1 receptor agonists stimulate ANGPTL8 production through the PI3K/Akt pathway in a GLP-1 receptor-dependent manner.
Liu J; Yang K; Xiao W; Le Y; Lang S; Zhang J; Wei R; Yang J; Hong T
Peptides; 2018 Aug; 106():83-90. PubMed ID: 30003931
[TBL] [Abstract][Full Text] [Related]
6. Exenatide exerts a PKA-dependent positive inotropic effect in human atrial myocardium: GLP-1R mediated effects in human myocardium.
Wallner M; Kolesnik E; Ablasser K; Khafaga M; Wakula P; Ljubojevic S; Thon-Gutschi EM; Sourij H; Kapl M; Edmunds NJ; Kuzmiski JB; Griffith DA; Knez I; Pieske B; von Lewinski D
J Mol Cell Cardiol; 2015 Dec; 89(Pt B):365-75. PubMed ID: 26432951
[TBL] [Abstract][Full Text] [Related]
7. Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA- and PI3K/Akt-dependent pathways and requires GLP-1 receptor.
Erdogdu O; Nathanson D; Sjöholm A; Nyström T; Zhang Q
Mol Cell Endocrinol; 2010 Aug; 325(1-2):26-35. PubMed ID: 20452396
[TBL] [Abstract][Full Text] [Related]
8. Exendin-4 inhibits structural remodeling and improves Ca
Chen J; Wang D; Wang F; Shi S; Chen Y; Yang B; Tang Y; Huang C
Peptides; 2017 Apr; 90():69-77. PubMed ID: 28242257
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.
Oeseburg H; de Boer RA; Buikema H; van der Harst P; van Gilst WH; Silljé HH
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1407-14. PubMed ID: 20448207
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of metformin with liraglutide against endothelial dysfunction through GLP-1 receptor and PKA signalling pathway.
Ke J; Liu Y; Yang J; Lu R; Tian Q; Hou W; Wang G; Wei R; Hong T
Sci Rep; 2017 Feb; 7():41085. PubMed ID: 28145471
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho-dependent mechanism.
Wang D; Luo P; Wang Y; Li W; Wang C; Sun D; Zhang R; Su T; Ma X; Zeng C; Wang H; Ren J; Cao F
Diabetes; 2013 May; 62(5):1697-708. PubMed ID: 23364453
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism.
Liu L; Liu J; Wong WT; Tian XY; Lau CW; Wang YX; Xu G; Pu Y; Zhu Z; Xu A; Lam KS; Chen ZY; Ng CF; Yao X; Huang Y
Hypertension; 2012 Sep; 60(3):833-41. PubMed ID: 22868389
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1 activates endothelial nitric oxide synthase in human umbilical vein endothelial cells.
Ding L; Zhang J
Acta Pharmacol Sin; 2012 Jan; 33(1):75-81. PubMed ID: 22120969
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotection by exenatide: A novel mechanism via improving mitochondrial function involving the GLP-1 receptor/cAMP/PKA pathway.
Chang G; Liu J; Qin S; Jiang Y; Zhang P; Yu H; Lu K; Zhang N; Cao L; Wang Y; Li Y; Zhang D
Int J Mol Med; 2018 Mar; 41(3):1693-1703. PubMed ID: 29286061
[TBL] [Abstract][Full Text] [Related]
15. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice.
Lu J; Xiang G; Liu M; Mei W; Xiang L; Dong J
Atherosclerosis; 2015 Dec; 243(2):438-48. PubMed ID: 26520898
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1 attenuates endothelial barrier injury in diabetes via cAMP/PKA mediated down-regulation of MLC phosphorylation.
Tang ST; Tang HQ; Su H; Wang Y; Zhou Q; Zhang Q; Wang Y; Zhu HQ
Biomed Pharmacother; 2019 May; 113():108667. PubMed ID: 30852419
[TBL] [Abstract][Full Text] [Related]
17. Exendin-4 protects endothelial cells from lipoapoptosis by PKA, PI3K, eNOS, p38 MAPK, and JNK pathways.
Erdogdu O; Eriksson L; Xu H; Sjöholm A; Zhang Q; Nyström T
J Mol Endocrinol; 2013 Apr; 50(2):229-41. PubMed ID: 23343509
[TBL] [Abstract][Full Text] [Related]
18. The GLP-1 receptor agonists exendin-4 and liraglutide alleviate oxidative stress and cognitive and micturition deficits induced by middle cerebral artery occlusion in diabetic mice.
Li PC; Liu LF; Jou MJ; Wang HK
BMC Neurosci; 2016 Jun; 17(1):37. PubMed ID: 27296974
[TBL] [Abstract][Full Text] [Related]
19. Effects of glucagon-like peptide-1 on advanced glycation endproduct-induced aortic endothelial dysfunction in streptozotocin-induced diabetic rats: possible roles of Rho kinase- and AMP kinase-mediated nuclear factor κB signaling pathways.
Tang ST; Zhang Q; Tang HQ; Wang CJ; Su H; Zhou Q; Wei W; Zhu HQ; Wang Y
Endocrine; 2016 Jul; 53(1):107-16. PubMed ID: 26758998
[TBL] [Abstract][Full Text] [Related]
20. Salidroside improves endothelial function and alleviates atherosclerosis by activating a mitochondria-related AMPK/PI3K/Akt/eNOS pathway.
Xing SS; Yang XY; Zheng T; Li WJ; Wu D; Chi JY; Bian F; Bai XL; Wu GJ; Zhang YZ; Zhang CT; Zhang YH; Li YS; Jin S
Vascul Pharmacol; 2015 Sep; 72():141-52. PubMed ID: 26187353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
